Clinical Trials Logo

Filter by:
NCT ID: NCT06236100 Recruiting - Clinical trials for Substance-Related Disorders

Evaluating an Adverse Childhood Experience-Targeting Advocate Model of a Substance Use Prevention Program

Start date: November 29, 2023
Phase: N/A
Study type: Interventional

Primary Objective: Conduct a rigorous evaluation of a prevention-based intervention designed to mitigate the harms of adverse childhood experiences (ACEs) exposure and prevent future ACEs, substance use, and overdose within 36 communities experiencing a disproportionate burden of substance use and ACEs. The study has three aims: (1) use a cluster randomized controlled trial to test effectiveness of the Strengthening Families Program (SFP) + Family Advocate (FA) intervention on substance use, overdose, and ACEs in 18 communities compared with SFP-only in 18 communities; (2) conduct a robust process evaluation informed by the Consolidated Framework for Implementation Research (CFIR) to explore implementation barriers and facilitators; and (3) conduct a cost evaluation to accurately estimate the costs required to implement SFP and SFP+FA and assess the cost-effectiveness of SFP+FA relative to SFP alone. Findings will provide a roadmap about the best ways to help disproportionately affected communities prevent substance use, overdose, and ACEs.

NCT ID: NCT06236087 Not yet recruiting - Overdose Clinical Trials

Overdose Prevention Centers and Behavioral Health

Start date: March 15, 2024
Phase:
Study type: Observational

The aims of this study are: (Aim 1) Identify sources of heterogeneous impacts of opioid prevention center (OPC) use on non-fatal and fatal overdose risk among individuals with histories of polysubstance use (PSU); (Aim 2) Estimate the impact of OPC use on treated psychiatric events among clients with histories of PSU, and; (Aim 3) Assess the barriers and facilitators of integrating mental health services into existing syringe service and OPC delivery models.

NCT ID: NCT06235996 Active, not recruiting - Chronic Pain Clinical Trials

Effects of Musical Intervention on Patient Pain and Anxiety for Office-based Procedures

Start date: January 1, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if the use of musical intervention reduces patient anxiety and provides a less painful experience during office-based procedures in a pain management clinic setting.

NCT ID: NCT06235970 Recruiting - Clinical trials for Transcranial Electrical Stimulation (tES)

Cognitive Enhancement Through Model-based and Individualized Neurostimulation

Start date: February 13, 2024
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to learn about the effects of transcranial electric stimulation on attentional control and brain dynamics in healthy adults. The main questions are: Does stimulation affect how subjects exert attentional control? Do mathematical models predict brain activity changes in response to stimulation? Participants will have electroencephalography (EEG) brain data recorded while: They sit relaxed They receive stimulation, while relaxed They receive stimulation while completing computerized tasks to measure cognitive abilities ("cognitive tasks") They receive sham (ineffective) stimulation during cognitive tasks

NCT ID: NCT06235905 Recruiting - Clinical trials for Major Depressive Disorder

Open-Label of SPN-820 in Adults With Major Depressive Disorder

Start date: February 15, 2024
Phase: Phase 2
Study type: Interventional

This study will evaluate the efficacy and safety of SPN-820 in Adults With Major Depressive Disorder (MDD)

NCT ID: NCT06235814 Recruiting - Clinical trials for Papillary Thyroid Cancer

Molecular Analysis for Precision Surgery in Thyroid Cancer Trial

MAPS
Start date: July 30, 2024
Phase: N/A
Study type: Interventional

Ideal surgical extent for differentiated thyroid cancer remains unclear. Routine use of molecular analysis in biopsy-proven thyroid cancer could provide important prognostic information to help guide extent of surgery - thyroid lobectomy versus total thyroidectomy. This is a pilot feasibility study for the use of routine molecular analysis in Bethesda V and VI thyroid cancers, with randomization of the intermediate-molecular risk subgroup to thyroid lobectomy and total thyroidectomy. The investigators hypothesize that patients will 1) agree to preoperative molecular analysis, and 2) 50% of intermediate-risk patients will agree to and follow through with randomization. This will be a pilot study for a future randomized controlled trial (RTC) to compare between the two surgical approaches in intermediate-molecular risk thyroid cancer.

NCT ID: NCT06235801 Recruiting - Myeloid Leukemia Clinical Trials

A Phase I/II Study of Gilteritinib and Momelotinib for Patients With Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia

Start date: May 22, 2024
Phase: Phase 1/Phase 2
Study type: Interventional

To learn the recommended dose of momelotinib that can be given in combination with gilteritinib to participants with AML.

NCT ID: NCT06235671 Not yet recruiting - Cancer Clinical Trials

Effects of Chiropractic on Chronic Cancer-related Fatigue

CAN
Start date: March 1, 2024
Phase: N/A
Study type: Interventional

The primary aims of the proposed trial are centered around examining the feasibility of conducting a prospective, chiropractic intervention study on a population of cancer survivors living in and around Atlanta, Georgia. This includes evaluating various implementation outcomes including recruitment, adherence, tolerability, retention, acceptability, and data fidelity. The results of this trial will inform the design of a future randomized controlled trial (RCT) that has an increased focus on the efficacy/effectiveness of chiropractic care on chronic cancer-related fatigue (CCRF) and other cancer-related sequelae in cancer survivors.

NCT ID: NCT06235658 Recruiting - Clinical trials for Cardiovascular Diseases in Old Age

Yoga in Older Cardiac Patients

Start date: November 15, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to compare, at 3 months, the effects of a yoga intervention on physical health, including balance, muscle strength, physical activity levels, cardiac autonomic function, and physical vulnerability, as well as psychological health, including depressive symptoms and anxiety, in cardiac patients who are older than 65 years old and randomized to the intervention or control group. The main questions aim to 1) determine if yoga can improve physical health outcomes such as balance, muscle strength, cardiac function, and physical vulnerability in older adults with cardiovascular disease, and 2) determine if yoga can positively impact psychological health, including reducing depressive symptoms and anxiety in this population. Participants in the intervention group will attend yoga sessions twice a week for three months. The intervention group will be asked to complete surveys and physical function assessments at the beginning and three months later. Researchers will compare the intervention group and the control group to see if there is any difference and improvement in physical and psychological health between the two groups.

NCT ID: NCT06235632 Enrolling by invitation - Cannabis Clinical Trials

Responsible Marijuana Sales Practices to Reduce the Risk of Selling to Intoxicated Customers

Start date: October 17, 2023
Phase: N/A
Study type: Interventional

The new recreational marijuana markets are contributing to polysubstance-impaired driving and other harms, especially when marijuana is used in combination with alcohol, by selling marijuana to obviously-intoxicated customers. In this study, the effectiveness of an intervention to reduce the risk of marijuana sales to obviously-intoxicated customers will be tested in the state-licensed recreational marijuana market in Oregon, one of the first states to ban such sales. The intervention will combine efforts by state regulators to increase deterrence of the state law prohibiting marijuana sales to obviously-intoxicated customers with training of store personnel to recognize signs of intoxication and refuse sales. It will also include testing the rate at which visibly intoxicated customers are refused alcohol at nearby establishments that sell alcohol either on-site or off-site